DOCSLIB.ORG

Frank Macdonald RN, MN

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

UNIT 16 (OPTION) Alterations in Endocrine Function Lorraine Anderson, Ph.D. Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary Unit 16 Alterations in Endocrine Function 1 Unit 16 Table of Contents Overview....................................................................................................4 Aim ....................................................................................................... 4 Objectives ................................................................................................ 4 Resources................................................................................................. 5 Web Links................................................................................................ 5 Section 1: Mechanisms of Hormone Regulation ....................................................6 Learning Activity #1 ................................................................................... 6 Regulation of Hormone Action ....................................................................... 6 Learning Activity #2 ................................................................................... 7 Hormone Transport .................................................................................... 7 Cellular Mechanisms of Hormone Release ......................................................... 7 Structure and Function of Endocrine Glands....................................................... 9 Hypothalamic Trophic Hormones ................................................................. 10 Anterior Pituitary Trophic Hormones ............................................................. 10 Other Anterior Pituitary Hormones ............................................................... 10 Posterior Pituitary Hormones....................................................................... 11 Learning Activity #3 ................................................................................. 12 Thyroid Gland......................................................................................... 12 Learning Activity #4 ................................................................................. 13 Adrenal Glands ....................................................................................... 13 Learning Activity #5 ................................................................................. 15 Section 2: Alterations of Hormonal Regulation ...................................................16 Mechanism of Hormonal Alterations.............................................................. 16 Alterations of the Hypothalamic-Pituitary System .............................................. 16 Learning Activity #6 ................................................................................. 18 Alterations of the Thyroid Function ............................................................... 19 Learning Activity #7 ................................................................................. 22 Alterations of Adrenal Function.................................................................... 23 Learning Activity #8 ................................................................................. 24 Final Thoughts...........................................................................................25 References ................................................................................................26 Glossary...................................................................................................27 Acronym List .............................................................................................28 Checklist of Requirements ............................................................................29 Required Readings ................................................................................... 29 Required Activities ................................................................................... 29 Answers to Learning Activities.......................................................................30 Learning Activity #1 ................................................................................. 30 Learning Activity #2 ................................................................................. 30 Learning Activity #3 ................................................................................. 30 Learning Activity #4 ................................................................................. 30 Learning Activity #5 ................................................................................. 30 Learning Activity #6 ................................................................................. 31 Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary 2 Unit 16 Alterations in Endocrine Function Learning Activity #7 ................................................................................. 31 Learning Activity #8 ................................................................................. 31 Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary Unit 16 Alterations in Endocrine Function 3 UNIT 16 Alterations in Endocrine Function The regulation of homeostasis by the endocrine system is both complex and subtle. During your nursing career you will encounter patients with mild to significant alterations in endocrine regulation. Your role as patient educator is of particular importance in the successful long-term management of these disorders. It is hoped that by increasing your own understanding of endocrine pathophysiology, your skills in assessment and patient education will be improved. This module will contain two basic components: the mechanisms of hormonal regulation and alterations of hormonal regulation. Each component is further subdivided into hypothalamic-pituitary, thyroid and adrenal sections. Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary 4 Unit 16 Alterations in Endocrine Function Overview Aim The general aim of this module is to facilitate your understanding of the mechanisms underlying hormone regulation and hormonal alterations. Upon completion of this unit, you will have a thorough understanding of the regulation of hormone release and transport. You will be introduced to the cellular mechanisms of hormone release and you will review the structure and function of the endocrine glands. You will have a good understanding of the pathophysiology, clinical manifestations and evaluation and treatment for most of the endocrine diseases you will encounter during your nursing career. Objectives On completion of this unit, you will be able to: 1. Name the five general functions of the endocrine system. 2. Be able to identify the following hormones as proteins, polypeptides, amines or lipids: growth hormone, prolactin, adrenocorticotropic hormone, antidiuretic hormone, oxytocin, epinephrine, thyroid hormone, glucocorticoids, aldosterone, estrogen and testosterone. 3. Name the 3 basic patterns of hormone release. 4. Define signal transduction, first and second messengers and identify at least two second messengers. 5. Describe the structural relationship between the hypothalamus and the anterior pituitary and posterior pituitary. 6. Name the two posterior pituitary hormones and describe their actions. 7. Describe the synthesis, regulation of release and actions of thyroid hormone, cortisol, aldosterone, adrenal estrogens/androgens and epinephrine. 8. Describe the various mechanisms of hormone alteration. 9. Describe the pathophysiology, clinical manifestations, evaluation and treatment of the following disorders: a. Syndrome of inappropriate antidiuretic hormone (SIADH) b. Diabetes insipidus c. Hypopituitary disorder d. Hyperpituitarism (primary adenoma and acromegaly) e. Thyrotoxicosis f. Hypothyroidism (primary, congenital) g. Disorders of the Adrenal Cortex (Cushing’s Disease, hypersecretion of adrenal androgens/estrogens and hypocortical functioning) h. Disorders of the adrenal medulla Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary Unit 16 Alterations in Endocrine Function 5 Resources Required McCance, K., & Huether, S. (2001). Pathophysiology: The biologic basis for disease in adults and children (4th ed.). St. Louis: Mosby. Pages: 597-610; 614-618; 24-638, (including Table 20-2) and 655-666. Print Companion: Alterations in Endocrine Function Learning Activities Student Activities One to Eight Supplemental Materials Student Activity Nine Web Links All web links in this unit can be accessed through the Web CT system. Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary 6 Unit 16 Alterations in Endocrine Function Section 1: Mechanisms of Hormone Regulation Read: McCance, K., & Huether, S. (2001). Pages: 597-598. Hormones may be classified by structure. Review Table 19-1 on page 626 of McCance and Huether. Recall that thyroid hormone, epinephrine and norepinephrine (amines) are derived from a single amino acid – tyrosine. For an overview of the interactions between hormones and their receptors, follow this link: Colorado State University http://arbl.cvmbs.colostate.edu/hbooks/pathphys/endocrine/moaction/ Learning Activity #1 Match each of the hormones with its structural category. a. protein _____ 1. Mineralcorticoids – Aldosterone b. polypeptide _____ 2. Growth Hormone c. amine _____ 3. Thyroid Hormone d. lipid _____
Recommended publications
  • HYPOPITUITARISM YOUR QUESTIONS ANSWERED Contents

    HYPOPITUITARISM YOUR QUESTIONS ANSWERED Contents

    PATIENT INFORMATION HYPOPITUITARISM YOUR QUESTIONS ANSWERED Contents What is hypopituitarism? What is hypopituitarism? 1 What causes hypopituitarism? 2 The pituitary gland is a small gland attached to the base of the brain. Hypopituitarism refers to loss of pituitary gland hormone production. The What are the symptoms and signs of hypopituitarism? 4 pituitary gland produces a variety of different hormones: 1. Adrenocorticotropic hormone (ACTH): controls production of How is hypopituitarism diagnosed? 6 the adrenal gland hormones cortisol and dehydroepiandrosterone (DHEA). What tests are necessary? 8 2. Thyroid-stimulating hormone (TSH): controls thyroid hormone production from the thyroid gland. How is hypopituitarism treated? 9 3. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH): LH and FSH together control fertility in both sexes and What are the benefits of hormone treatment(s)? 12 the secretion of sex hormones (estrogen and progesterone from the ovaries in women and testosterone from the testes in men). What are the risks of hormone treatment(s)? 13 4. Growth hormone (GH): required for growth in childhood and has effects on the entire body throughout life. Is life-long treatment necessary and what precautions are necessary? 13 5. Prolactin (PRL): required for breast feeding. How is treatment followed? 14 6. Oxytocin: required during labor and delivery and for lactation and breast feeding. Is fertility possible if I have hypopituitarism? 15 7. Antidiuretic hormone (also known as vasopressin): helps maintain normal water Summary 15 balance. What do I need to do if I have a pituitary hormone deficiency? 16 Glossary inside back cover “Hypo” is Greek for “below normal” or “deficient” Hypopituitarism may involve the loss of one, several or all of the pituitary hormones.
  • The Immuno-Neuroendocrine Interface

    The Immuno-Neuroendocrine Interface

    Amendment history: Erratum (December 2001) Series Introduction: The immuno-neuroendocrine interface Shlomo Melmed J Clin Invest. 2001;108(11):1563-1566. https://doi.org/10.1172/JCI14604. Perspective The CNS and the various endocrine organs are linked in a dynamic manner through networks of reciprocal interactions that allow for both long-term adaptation and short-term shifts in environmental conditions. These regulatory systems embrace the hypothalamus, the pituitary gland, and any of several target glands, including the adrenal gland and the thyroid. Because the anterior pituitary gland secretes at least six key hormones — adrenocorticotropin (ACTH), growth hormone (GH), prolactin (PRL), thyrotropin (TSH), and the gonadotropins follicle stimulating hormone and luteinizing hormone — such diverse parameters as cell integrity, stress responses, growth, development, reproduction, and energy homeostasis are all directly or indirectly under central control (1). In addition, largely because of the dominant role of the hypothalamo-pituitary-adrenal (HPA) axis, inflammation and immunity are also subject to neuroendocrine effects. The articles in this Perspective series explore some of the developmental, physiological, and molecular interactions occurring at the immuno-neuroendocrine interface. Control of pituitary function Three tiers of control subserve regulation of anterior pituitary trophic hormone secretion (2). First, the hypothalamus synthesizes and secretes releasing and inhibiting hormones, which traverse the hypothalamo-pituitary portal system and bind to specific anterior pituitary G protein−linked transmembrane […] Find the latest version: https://jci.me/14604/pdf PERSPECTIVE SERIES Neuro-immune interface Shlomo Melmed, Series Editor SERIES INTRODUCTION The immuno-neuroendocrine interface Shlomo Melmed Cedars-Sinai Research Institute, University of California Los Angeles, School of Medicine, Los Angeles, California 90048, USA.
  • Acromegaly and the Surgical Treatment of Giant Nose

    Acromegaly and the Surgical Treatment of Giant Nose

    ARC Journal of Clinical Case Reports Volume 3, Issue 4, 2017, PP 19-21 ISSN No. (Online) 2455-9806 DOI: http://dx.doi.org/10.20431/2455-9806.0304005 www.arcjournals.org Acromegaly and the Surgical Treatment of Giant Nose Lorna Langstaff, MBBS*, Peter Prinsley, MB ChB James Paget University Hospital, Lowestoft Road, NR31 6LA, UK *Corresponding Author: Lorna Langstaff, MBBS, James Paget University Hospital, Lowestoft Road, NR31 6LA, UK, Email: [email protected] Abstract Introduction: The endocrinological changes caused by hyperpituitarism are well managed and reversed. However, the facial changes associated with acromegaly can be permanent and cause distress and concern to patients. Case History: We present the case of an acromegalic women, previously treated for hyperpituitarism, pre- senting with persistent facial changes and a large nose. This was successfully addressed with rhinoplasty, clinical photography is provided. Discussion: The nasal changes associated with acromegaly are challenging but can be successfully treated with rhinoplasty. We discuss the few cases previously mentioned in the literature and the pathophysiology involved in the changes of facial appearance found in acromegalic patients. Keywords: Acromegaly, Giant Nose, Rhinoplasty, Hyperpituitarism Search Strategy: exp “Nasal Bone” or “Nasal Cartilages” or “Nasal Septum” or “Nasal Surgical proce- dure” and Acromegaly or Gigantism or hyperpitu* 1. INTRODUCTION 2. CASE REPORT Acromegaly characteristically causes enlarge- The patient is a 54 year old lady who presented ment of the mandible, zygomatic arches and 10 years after successful treatment for hyperpi- supraorbital ridges, as well as an enlarged nose tuitarism caused by a pituitary adenoma. The and on occasion’s nasal obstruction.
  • Hormone Research

    Hormone Research

    RECENT PROGRESS IN HORMONE RESEARCH Edited by ANTHONY R. MEANS VOLUME 58 The Human Genome and Endocrinology “Recent Progress in Hormone Research” is an annual publication of The Endocrine Society that is published under the editorial auspices of Endocrine Reviews. The Endocrine Society 8401 Connecticut Avenue, Suite 900 Chevy Chase, Maryland 20815 Copyright 2003 by The Endocrine Society All Rights Reserved The reproduction or utilization of this work in any form or in any electronic, mechanical, or other means, now known or hereafter invented, including photocopying or recording and in any information storage or retrieval system, is forbidden, except as may be expressly permitted by the 1976 Copyright Act or by permission of the publisher. ISBN 0–879225-48-4 CONTENTS Senior Author Correspondence Information v 1. A Functional Proteomics Approach to Signal Transduction 1 Paul R. Graves and Timothy A.J. Haystead 2. The Use of DNA Microarrays to Assess Clinical Samples: The Transition from Bedside to Bench to Bedside 25 John A. Copland, Peter J. Davies, Gregory L. Shipley, Christopher G. Wood, Bruce A. Luxon, and Randall J. Urban 3. Gene Expression Profiling for Prediction of Clinical Characteristics of Breast Cancer 55 Erich Huang, Mike West, and Joseph R. Nevins 4. Statistical Approach to DNA Chip Analysis 75 N.M. Svrakic, O. Nesic, M.R.K. Dasu, D. Herndon, and J.R. Perez-Polo 5. Identification of a Nuclear Factor Kappa B-dependent Gene Network 95 Bing Tian and Allan R. Brasier 6. Role of Defective Apoptosis in Type 1 Diabetes and Other Autoimmune Diseases 131 Takuma Hayashi and Denise L.
  • Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose

    Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose

    Case Study TheScientificWorldJOURNAL (2010) 10, 126–134 ISSN 1537-744X; DOI 10.1100/tsw.2010.24 Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose Pulse Steroids, Followed by Azathioprine, on the Pituitary Mass and Endocrine Abnormalities — Report of a Case and Literature Review Lorenzo Curtò1,*, Maria L. Torre1, Oana R. Cotta1, Marco Losa2, Maria R. Terreni3, Libero Santarpia4, Francesco Trimarchi1, and Salvatore Cannavò1 1Department of Medicine and Pharmacology - Section of Endocrinology, University of Messina, Italy; 2Department of Neurosurgery and 3Department of Pathology, San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy; 4Translational Research Unit, Department of Oncology, Hospital of Prato and Istituto Toscana Tumori, Florence, Italy E-mail: [email protected] Received September 26, 2009; Revised January 8, 2010; Accepted January 11, 2010; Published January 21, 2010 We report on a man with a progressively increasing pituitary mass, as demonstrated by MRI. It produced neurological and ophthalmological symptoms, and, ultimately, hypopituitarism. MRI also showed enlargement of the pituitary stalk and a dural tail phenomenon. An increased titer of antipituitary antibodies (1:16) was detected in the serum. Pituitary biopsy showed autoimmune hypophysitis (AH). Neither methylprednisolone pulse therapy nor a subsequent treatment with azathioprine were successful in recovering pituitary function, or in inducing a significant reduction of the pituitary mass after an initial, transient clinical and neuroradiological improvement. Anterior pituitary function evaluation revealed persistent hypopituitarism. AH is a relatively rare condition, particularly in males, but it represents an emerging entity in the diagnostic management of pituitary masses. This case shows that response to appropriate therapy for hypophysitis may not be very favorable and confirms that diagnostic management of nonsecreting pituitary masses can be a challenge.
  • Pituitary Adenomas: from Diagnosis to Therapeutics

    Pituitary Adenomas: from Diagnosis to Therapeutics

    biomedicines Review Pituitary Adenomas: From Diagnosis to Therapeutics Samridhi Banskota 1 and David C. Adamson 1,2,3,* 1 School of Medicine, Emory University, Atlanta, GA 30322, USA; [email protected] 2 Department of Neurosurgery, Emory University, Atlanta, GA 30322, USA 3 Neurosurgery, Atlanta VA Healthcare System, Decatur, GA 30322, USA * Correspondence: [email protected] Abstract: Pituitary adenomas are tumors that arise in the anterior pituitary gland. They are the third most common cause of central nervous system (CNS) tumors among adults. Most adenomas are benign and exert their effect via excess hormone secretion or mass effect. Clinical presentation of pituitary adenoma varies based on their size and hormone secreted. Here, we review some of the most common types of pituitary adenomas, their clinical presentation, and current diagnostic and therapeutic strategies. Keywords: pituitary adenoma; prolactinoma; acromegaly; Cushing’s; transsphenoidal; CNS tumor 1. Introduction The pituitary gland is located at the base of the brain, coming off the inferior hy- pothalamus, and weighs no more than half a gram. The pituitary gland is often referred to as the “master gland” and is the most important endocrine gland in the body because it regulates vital hormone secretion [1]. These hormones are responsible for vital bodily Citation: Banskota, S.; Adamson, functions, such as growth, blood pressure, reproduction, and metabolism [2]. Anatomically, D.C. Pituitary Adenomas: From the pituitary gland is divided into three lobes: anterior, intermediate, and posterior. The Diagnosis to Therapeutics. anterior lobe is composed of several endocrine cells, such as lactotropes, somatotropes, and Biomedicines 2021, 9, 494. https: corticotropes, which synthesize and secrete specific hormones.
  • Early Descriptions of Acromegaly and Gigantism and Their Historical Evolution As Clinical Entities

    Early Descriptions of Acromegaly and Gigantism and Their Historical Evolution As Clinical Entities

    Neurosurg Focus 29 (4):E1, 2010 Early descriptions of acromegaly and gigantism and their historical evolution as clinical entities Historical vignette ANTONIOS Mamm IS , M.D., JE A N AN D ERSON ELOY , M.D., A N D Jam ES K. LIU, M.D. Department of Neurological Surgery, Division of Otolaryngology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Neurological Institute of New Jersey, Newark, New Jersey Giants have been a subject of fascination throughout history. Whereas descriptions of giants have existed in the lay literature for millennia, the first attempt at a medical description was published by Johannes Wier in 1567. How- ever, it was Pierre Marie, in 1886, who established the term “acromegaly” for the first time and established a distinct clinical diagnosis with clear clinical descriptions in 2 patients with the characteristic presentation. Multiple autopsy findings revealed a consistent correlation between acromegaly and pituitary enlargement. In 1909, Harvey Cushing postulated a “hormone of growth” as the underlying pathophysiological trigger involved in pituitary hypersecretion in patients with acromegaly. This theory was supported by his observations of clinical remission in patients with ac- romegaly in whom he had performed hypophysectomy. In this paper, the authors present some of the early accounts of acromegaly and gigantism, and describe its historical evolution as a medical and surgical entity. (DOI: 10.3171/2010.7.FOCUS10160) KEY WOR D S • acromegaly • gigantism • historical vignette • pituitary tumor CROMEG A LIC individuals and giants have been the very marked prognathism, flattened and indented laterally, as if the cheeks had been elevated by a blow from the hatchet on subject of fascination for millennia.
  • Bullnyacadmed00577-0034.Pdf

    Bullnyacadmed00577-0034.Pdf

    APRIL 2 2 7 l~~~~~~ARL141940 2 HYPERPITU ITARI SM AND HYPOPITUITARI SM* LEO M. DAVIDOFF INTRODUCTION ri HE pituitary gland, in the words of Harvey Cushing,1 OH| "exercises direct or indirect control over an unsuspected number of biochemical processes of utmost importance to the economy of the body." There are, for this reason, undoubtedly innumerable states, some pathological, others bordering upon the pathological, in which dysfunction of the pituitary gland is involved. However, our present state of knowledge of pituitary dysfunction without demonstrable morphologic changes in the pituitary gland is such that it is dangerous speculation to attempt to ascribe many bizarre conditions, as claimed by uncontrolled and popular endocrinology, to improper secretion of the pituitary gland. Indeed, there must be a considerable margin of safety in the quan- tity of functioning glandular tissue of the anterior lobe of the pituitary body since one not infrequently sees patients with partial destruction of this organ by tuberculosis, syphilis or embolic phenomena without any detectable symptoms ascribable to loss of pituitary secretion. However, sufficient experimental data and clinical and pathological evidence exist to make possible the recognition of two important classes of pituitary disturbances, namely, hyperactivity and hypofunction of this gland. Of all the verified diseases of the pituitary gland producing one or the other of these groups of symptoms, the commonest is the adenoma- tous tumor.2 The type of clinical response to such a tumor varies with the type of cell from which the tumor arises. HYPERPITUITARISM ACROMEGALY Definition: Acromegaly is a disease which is characterized by a spe- cific type of pituitary adenoma and an overgrowth of the terminal, thus acral, parts of the skeleton such as the nose, mandible, hands and feet.
  • Pathology of the Endocrine System

    Pathology of the Endocrine System

    Pathology of the Endocrine System ผูชวยศาสตราจารย แพทยหญิง จุลินทร สําราญ ภาควิชาพยาธิวิทยา คณะแพทยศาสตร Endocrine system 1. Endocrine organs 2. Endocrine components in mixed organs 3. Diffuse endocrine system – “paracrine” 1 Endocrine-related Problems • Overproduction of a hormone • Underproduction of a hormone • Nonfunctional receptors that cause target cells to become insensitive to hormones Hypothalamus and Pituitary gland 2 Hypothalamus – Pituitary gland Pituitary gland Adenohypophysis Neurohypophysis Roof of mouth – Rathke’s pouch Floor of diencephalon 3 Pituitary gland Pituitary Hormones 4 Clinical Manifestations of Pituitary Disease • Hyperpituitarism • Hypopituitarism • Local mass effects • Diseases of the posterior pituitary: Increased or decreased ADH Hyperpituitarism • Increased secretion of one or more of pituitary hormones – Pituitary adenoma – Pituitary hyperplasia – Pituitary carcinoma – Secretion of hormones by nonpituitary tumors – Hypothalamic disorder 5 Hypopituitarism • Deficient secretion of one or more of pituitary hormones – Pituitary tumor compressing normal tissue – Sheehan Syndrome: ischemic injury from PPH – Pituitary apoplexy: hemorrhage or infarct in normal tissue or inactive adenoma – Trauma, surgery or radiation – Infiltrative disease including infection, inflammation, and some tumors – Genetic abnormalities of pituitary development – Empty sella syndrome Local mass effects • Headaches: Increase intracranial pressure – streching of dura • Visual field defect: Nasal retinal fiber compression • Cranial nerve
  • Mosby's PATHOLOGY for Massage Therapists

    Mosby's PATHOLOGY for Massage Therapists

    Mosby’s PATHOLOGY Lesson 7.1 Objectives for Massage Therapists Discuss anatomic structures and physiologic processes related to the endocrine system. Outline the glandular sources of major hormones, as well as their primary effects. Define diseases of the pituitary gland and list appropriate massage considerations. Chapter 7 Endocrine Pathologies Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. 2 Endocrine System Overview Effects of the Endocrine System Regulatory system Regulates activity of Regulates growth Responsible for helping maintain homeostasis smooth/cardiac and development Regulates Works with nervous system to coordinate muscle and some Regulates functioning of all body systems glands reproductive processes Uses hormones to communicate Regulates chemical Participates in composition and circadian rhythms volume of fluids Alters metabolism Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. 3 4 Types of Glands Types of Glands (cont'd.) Exocrine glands Endocrine (ductless) glands Sudoriferous : secretes perspiration Adrenals Sebaceous: secretes oil Gonads Ceruminous : secretes earwax Pancreas (islets) Digestive: secrete enzymes Parathyroids Mucous: secrete mucous Mucous: secrete mucous Pineal Pituitary Thyroid Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. Copyright © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. 5 6 Location of Endocrine Glands Pituitary Hormones ACTH, Adrenocorticotrophic hormone LH, luteinizing hormone ADH, antidiuretic hormone PRL, prolactin FSH, follicle -stimulating hormone TSH, thyroid -stimulating hormone From Salvo S: Massage therapy: principles and practice, ed 3, St.
  • The Endocrine Physiology 2 Inputs That Control Hormone Secretion • Control by Plasma Concentrations of Mineral Ions Or Organic Molecules

    The Endocrine Physiology 2 Inputs That Control Hormone Secretion • Control by Plasma Concentrations of Mineral Ions Or Organic Molecules

    The Endocrine Physiology 2 Inputs that Control Hormone Secretion • Control by Plasma Concentrations of mineral Ions or Organic molecules. For example, absorption of I- iodine ion increase output of thyroxine hormone by thyroid glands. • Control by Neurons – Nervous system can control hormone secretion in 4 ways. 1) Autonomic NS stimulates adrenal medulla to secrete epinephrine 2) Autonomic NS can stimulate or inhibit secretion of a hormone by an endocrine gland 3) neurohormones secreted by hypothalamus pass through blood to anterior pituitary body and influence the secretion of hormones by it. 4) Axons of some neurons of hypothalamus end in posterior pituitary lobe and release their hormones in it. • Control by Other Hormones – when the secretion of a hormone (thyroid stimulating hormone) causes the secretion of another hormone (triodothyronine), the 1st hormone is called a tropic hormone (thyrotropin). Most of these hormones also cause growth of gland (thyroid) secreting the hormone. For this action a tropic hormone is called a trophic hormone. I gave examples in parentheses. Types of Endocrine disorders • Hyposecretion is too little hormone. Primary hyposecretion can be due to partial damage of gland or enzyme deficiency or lack of nutrient in diet or infection etc. Secondary hyposecretion is caused due to deficiency of the tropic hormone though gland is in good condition. • Hypersecretion is too much hormone. It can also be primary or secondary on similar pattern to hyposecretion. • Hyporesponsiveness is reduced responsiveness of target cells to hormone. Most common type of Diabetes mellitus type 2 is caused due to hyporesponsiveness of target cells (muscle cells and adipose tissue).
  • UNIT 14 (OPTION) Alterations in Endocrine Function

    UNIT 14 (OPTION) Alterations in Endocrine Function

    UNIT 14 (OPTION) Alterations in Endocrine Function Lorraine Anderson, Ph.D. Rankin, Reimer & Then. © 2000 revised edition. NURS 461 Pathophysiology, University of Calgary Unit 16 Alterations in Endocrine Function 1 Unit 16 Table of Contents Overview....................................................................................................4 Aim ....................................................................................................... 4 Objectives ................................................................................................ 4 Resources................................................................................................. 5 Web Links................................................................................................ 5 Section 1: Mechanisms of Hormone Regulation ....................................................6 Learning Activity #1 ................................................................................... 6 Regulation of Hormone Action ....................................................................... 6 Learning Activity #2 ................................................................................... 7 Hormone Transport .................................................................................... 7 Cellular Mechanisms of Hormone Release ......................................................... 7 Structure and Function of Endocrine Glands....................................................... 9 Hypothalamic Trophic Hormones ................................................................